Concepedia

Courtney DiNardo

CD

Statistics

Publications

4

Citations

969

H-Index

4

Active since

2013

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Emory University

Baylor College of Medicine

Georgia Institute of Technology

Courtney DiNardo is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, molecular oncology, and oncology.

Publications per year

2013–2024

4

Publications

4

Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents

Hui Yang, Carlos E. Bueso‐Ramos, Courtney DiNardo et al. · Leukemia · 2013 · 684 citations · Full text

Medicine, Hematology, Oncology +10

Novel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cells

Dyana T. Saenz, Warren Fiskus, Yimin Qian et al. · Leukemia · 2017 · 184 citations · Full text

Medicine, Oncology, Pharmacology +12

BET protein bromodomain inhibitor-based combinations are highly active against post-myeloproliferative neoplasm secondary AML cells

Dyana T. Saenz, Warren Fiskus, Taghi Manshouri et al. · Leukemia · 2016 · 90 citations

Medicine, Oncology, Pharmacology +13

Outcomes of Patients With Newly Diagnosed AML and Hyperleukocytosis

Fadi Haddad, Koji Sasaki, Jayastu Senapati et al. · JCO Oncology Practice · 2024 · 11 citations

Medicine, Hematology, Oncology +15

1–4 of 4